An investment firm with offices worldwide manages a $30 million seed-stage fund that seeks to invest in companies across a variety of industries, but it is most interested in A.I. technology and data-oriented companies. The investment is general in term of equity, but convertible loans will be considered as well. The typical investment size ranges from $250K to $500K and seeks 25 new investments per year. The fund generally invests in seed stage, but occasionally will invest in Series A and Series B rounds with co-investors. The firm will consider new opportunities around the globe.
In healthcare, the firm is currently looking for new investments in the medical technology and healthcare IT sectors. The firm will not consider investments in biotech therapeutics or drug development space. For medical devices, the firm considers Class 1&2 devices, depending on the opportunity, but it is most interested in low-risk devices that do not need FDA approval. In healthcare IT, the firm looks to invest in companies developing m-Health and e-Health. In terms of stage of development, the current fund focuses on seed-stage investments. Historically, the firm was active in companies targeting digital health and clinical data platform.
The firm looks to invest in private companies across the globe. The firm prefers to invest in companies with a strong and full management team with significant growth potential.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com